Literature DB >> 27507861

Nonatheroscleotic Isolated Middle Cerebral Artery Disease May Be Early Manifestation of Moyamoya Disease.

Yeon-Jung Kim1, Joo Kyung Lee1, Sung-Ho Ahn1, Bum Joon Kim1, Dong-Wha Kang1, Jong S Kim1, Sun U Kwon2.   

Abstract

BACKGROUND AND
PURPOSE: Middle cerebral artery steno-occlusive disease (MCAD) is not an uncommon cause of ischemic stroke in young Asians. Aside from atherosclerosis, the pathogenesis of MCAD include various nonatherosclerotic vasculopathies, most of which are yet to be defined. This study investigated the pathogenesis of symptomatic isolated MCAD in young Asian patients using high-resolution magnetic resonance imaging (HR-MRI) and mutation analysis of RNF213.
METHODS: Patients aged <60 years with stroke or transient ischemic attack caused by MCAD were prospectively enrolled. Patients with a confirmed diagnosis of moyamoya disease, dissection, and vasculitis; with significant steno-occlusion in cerebral arteries other than the MCA; or with high-risk cardioembolic source were excluded. Using high-resolution MRI, patients were classified into an atherosclerosis group and a nonatherosclerosis group.
RESULTS: Eighty-one patients were enrolled, 45 (56.6%) in the atherosclerosis and 36 (44.4%) in the nonatherosclerosis group. The nonatherosclerosis group was significantly younger (P=0.013), had a smaller number of vascular risk factors (P=0.001), showed a lower homocysteine level (P<0.001), thinner intima-media thickness (P=0.006), and had more frequent heterozygotes at RNF213 (P=0.045) than the atherosclerosis group. Diffusion-weighted image lesion pattern showed no significant differences in assumed stroke mechanisms between the 2 groups.
CONCLUSIONS: Nonatherosclerotic pathogenesis are common in young Asians with symptomatic isolated MCAD. Clinical findings, high-resolution MRI features, and results of RNF213 mutation analysis suggest that moyamoya disease is responsible etiologically for a significant portion of nonatherosclerotic lesions. Symptomatic isolated MCAD may be an early manifestation of moyamoya disease in young Asian adults.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; cerebral arterial diseases; intracranial atherosclerosis; magnetic resonance imaging; moyamoya disease

Mesh:

Substances:

Year:  2016        PMID: 27507861     DOI: 10.1161/STROKEAHA.116.012751

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  Cerebral Angiography in Moyamoya Syndrome Secondary to Vasculopathy in Down Syndrome.

Authors:  Mohamed Shehabeldin; Doungporn Ruthirago; Yazan J Alderazi
Journal:  J Vasc Interv Neurol       Date:  2017-12

Review 2.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

3.  Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.

Authors:  Tong Zhang; Congrong Guo; Xin Liao; Jian Xia; XiaoXiao Wang; Jing Deng; Junxia Yan
Journal:  Environ Health Prev Med       Date:  2017-04-24       Impact factor: 3.674

Review 4.  Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.

Authors:  Xin Liao; Jing Deng; Wenjie Dai; Tong Zhang; Junxia Yan
Journal:  Environ Health Prev Med       Date:  2017-11-02       Impact factor: 3.674

Review 5.  Medical Treatment of Intracranial Atherosclerosis: An Update.

Authors:  Jong S Kim; Oh Young Bang
Journal:  J Stroke       Date:  2017-09-29       Impact factor: 6.967

Review 6.  Intracranial Large Artery Disease of Non-Atherosclerotic Origin: Recent Progress and Clinical Implications.

Authors:  Oh Young Bang; Kazunori Toyoda; Juan F Arenillas; Liping Liu; Jong S Kim
Journal:  J Stroke       Date:  2018-05-31       Impact factor: 6.967

7.  Rare RNF213 variants and the risk of intracranial artery stenosis/occlusion disease in Chinese population: a case-control study.

Authors:  Xin Liao; Tong Zhang; Bingyang Li; Shimin Hu; Junyu Liu; Jing Deng; Hongzhuan Tan; Junxia Yan
Journal:  BMC Med Genet       Date:  2019-03-29       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.